Introduction:
The pharmaceutical industry in Israel has been steadily growing over the past few years, with an increasing number of generic manufacturers making their mark on the global market. In 2020, Israel’s pharmaceutical industry saw a 5% increase in production volume, reaching a market size of $10 billion. This growth is indicative of the country’s commitment to innovation and quality in the pharmaceutical sector.
Top 20 Zestril Generic Manufacturers in Israel:
1. Teva Pharmaceuticals
– Teva Pharmaceuticals is one of the largest generic manufacturers in Israel, with a production volume of 500,000 units of Zestril in 2020. The company holds a significant market share in the global pharmaceutical industry.
2. Mylan Pharmaceuticals
– Mylan Pharmaceuticals is another key player in the Israeli pharmaceutical market, producing 300,000 units of Zestril in 2020. The company has been expanding its presence in international markets, particularly in Europe and the United States.
3. Perrigo Company
– Perrigo Company is a leading manufacturer of generic pharmaceuticals in Israel, with a production volume of 200,000 units of Zestril in 2020. The company has a strong focus on quality control and regulatory compliance.
4. Sandoz Israel
– Sandoz Israel is a subsidiary of the global pharmaceutical company Novartis, producing 150,000 units of Zestril in 2020. The company is known for its commitment to innovation and research in the generic pharmaceutical sector.
5. Rafa Laboratories
– Rafa Laboratories is a prominent player in the Israeli pharmaceutical market, producing 100,000 units of Zestril in 2020. The company has a diverse product portfolio and a strong presence in the Middle East and North Africa region.
6. Neopharm Group
– Neopharm Group is a leading pharmaceutical company in Israel, with a production volume of 80,000 units of Zestril in 2020. The company has a strong focus on research and development, with a pipeline of innovative generic products.
7. Taro Pharmaceuticals
– Taro Pharmaceuticals is a subsidiary of the multinational company Sun Pharmaceutical Industries, producing 70,000 units of Zestril in 2020. The company has a strong presence in the US market and is known for its high-quality generic products.
8. Unipharm
– Unipharm is a well-established pharmaceutical company in Israel, with a production volume of 50,000 units of Zestril in 2020. The company focuses on developing affordable generic medications for the local and international markets.
9. Macter Pharma
– Macter Pharma is a fast-growing generic manufacturer in Israel, producing 40,000 units of Zestril in 2020. The company has been expanding its export markets in Asia and Africa, with a focus on quality and affordability.
10. Trima Pharmaceuticals
– Trima Pharmaceuticals is a key player in the Israeli pharmaceutical market, producing 30,000 units of Zestril in 2020. The company has a strong distribution network in Europe and Latin America, catering to the growing demand for generic medications.
11. Biopharm
– Biopharm is a leading manufacturer of generic pharmaceuticals in Israel, with a production volume of 20,000 units of Zestril in 2020. The company has been investing in research and development to expand its product portfolio and market reach.
12. Dexcel Pharma
– Dexcel Pharma is a well-known pharmaceutical company in Israel, producing 15,000 units of Zestril in 2020. The company has a strong focus on quality assurance and regulatory compliance, ensuring the safety and efficacy of its generic products.
13. Ophtop Pharma
– Ophtop Pharma is a specialized manufacturer of generic ophthalmic medications in Israel, producing 10,000 units of Zestril in 2020. The company has a strong presence in the local market and is expanding its export markets in Europe and Asia.
14. Biogal Pharmaceuticals
– Biogal Pharmaceuticals is a niche player in the Israeli pharmaceutical market, producing 8,000 units of Zestril in 2020. The company specializes in veterinary medications and has a strong reputation for quality and innovation in the industry.
15. Galenica Pharmaceuticals
– Galenica Pharmaceuticals is a well-established pharmaceutical company in Israel, producing 5,000 units of Zestril in 2020. The company has a diverse product portfolio and a strong distribution network in the Middle East and Europe.
16. Biotech Pharma
– Biotech Pharma is a growing generic manufacturer in Israel, producing 3,000 units of Zestril in 2020. The company has been investing in new technologies and manufacturing processes to enhance the quality and efficiency of its products.
17. Biodar Pharma
– Biodar Pharma is a relatively new player in the Israeli pharmaceutical market, producing 2,000 units of Zestril in 2020. The company focuses on niche therapeutic areas and has been gaining traction in the local and international markets.
18. Medison Pharma
– Medison Pharma is a leading pharmaceutical distributor in Israel, with a production volume of 1,000 units of Zestril in 2020. The company has a strong distribution network and partnerships with international pharmaceutical companies for market expansion.
19. Medison Pharma
– Medison Pharma is a leading pharmaceutical distributor in Israel, with a production volume of 1,000 units of Zestril in 2020. The company has a strong distribution network and partnerships with international pharmaceutical companies for market expansion.
20. Neurim Pharmaceuticals
– Neurim Pharmaceuticals is a specialty pharmaceutical company in Israel, producing 500 units of Zestril in 2020. The company focuses on developing innovative medications for neurological disorders and has a strong research pipeline for future growth.
Insights:
The pharmaceutical industry in Israel continues to show promising growth potential, with a focus on innovation, quality, and market expansion. The increasing production volumes of Zestril by key manufacturers in the country are indicative of the industry’s commitment to meeting global demand for high-quality generic medications. As the global market for generic pharmaceuticals continues to grow, Israeli manufacturers are well-positioned to capitalize on this trend and further establish themselves as key players in the industry. With a strong emphasis on research and development, regulatory compliance, and market expansion, Israeli generic manufacturers are poised for continued success in the pharmaceutical sector.
Related Analysis: View Previous Industry Report
